{"date":"2025-06-22","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4147-2025-06-22-1907-v8aihy","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2025-06-22","time":"19:07:58","subject":"公告中裕新藥正式啟動TMB-365/380以每兩個月靜脈注射一次方式作為愛滋病維持治療2b期臨床試驗工作","clause":"第53款","fact_date":"2025-06-21","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2025-06-22 19:07，「公告中裕新藥正式啟動TMB-365/380以每兩個月靜脈注射一次方式作為愛滋病維持治療2b期臨床試驗工作」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}